Key Record Dates
| ClinicalTrials.gov Identifier: | NCT01872442 |
|---|---|
| Brief Title: | Combination of Dasatinib and Peg-Interferon Alpha 2b in First Line for Chronic Myeloid Leukemia in Chronic Phase |
| First Submitted : | May 14, 2013 |
| First Submitted that Met QC Criteria : | June 4, 2013 |
| First Posted : | June 7, 2013 (Estimate) |
| Last Update Submitted that Met QC Criteria : | February 7, 2020 |
| Last Update Posted : | February 10, 2020 |